H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 127 Citations 69,160 683 World Ranking 1142 National Ranking 689

Research.com Recognitions

Awards & Achievements

2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of investigation include Ovarian cancer, Cancer research, Cancer, Internal medicine and Metastasis. His research in Ovarian cancer is mostly focused on Ovarian carcinoma. His Cancer research research includes elements of Cancer cell, Gene silencing, microRNA and In vivo.

His Cancer research is multidisciplinary, relying on both Immunology, Immune system and Pathology. His research integrates issues of Gastroenterology, Endocrinology, Gynecology and Oncology in his study of Internal medicine. The Metastasis study combines topics in areas such as Carcinogenesis, Melanoma, Colorectal cancer and Survival analysis.

His most cited work include:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
  • Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
  • Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (796 citations)

What are the main themes of his work throughout his whole career to date?

Anil K. Sood focuses on Cancer research, Ovarian cancer, Internal medicine, Cancer and Oncology. Anil K. Sood has researched Cancer research in several fields, including Cancer cell, Gene silencing, Metastasis and In vivo. His studies deal with areas such as Apoptosis, RNA interference and Small interfering RNA as well as Gene silencing.

His Ovarian cancer study incorporates themes from Serous fluid, Pathology, Chemotherapy and Cell growth. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology. The Cancer study combines topics in areas such as microRNA, Immunology and Bioinformatics.

He most often published in these fields:

  • Cancer research (45.80%)
  • Ovarian cancer (45.90%)
  • Internal medicine (34.47%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (45.80%)
  • Ovarian cancer (45.90%)
  • Internal medicine (34.47%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cancer research, Ovarian cancer, Internal medicine, Oncology and Cancer. His work deals with themes such as Cancer cell, Metastasis and In vivo, which intersect with Cancer research. His Ovarian cancer research is multidisciplinary, relying on both Stage, Serous fluid, Laparoscopy and Disease.

Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His biological study deals with issues like Epidemiology, which deal with fields such as Propensity score matching. Many of his research projects under Cancer are closely connected to Olaparib with Olaparib, tying the diverse disciplines of science together.

Between 2018 and 2021, his most popular works were:

  • Circular RNAs in Cancer (134 citations)
  • Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation (97 citations)
  • exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids (89 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His primary scientific interests are in Cancer research, Ovarian cancer, Internal medicine, Cancer cell and Oncology. He combines subjects such as Cancer, Metastasis, Gene silencing and In vivo with his study of Cancer research. His Cancer research is multidisciplinary, incorporating perspectives in microRNA and Genome instability.

The concepts of his Ovarian cancer study are interwoven with issues in Adverse effect, Disease, Cisplatin and Fallopian tube. Anil K. Sood has included themes like Gastroenterology and Endocrinology in his Internal medicine study. His study in Cancer cell is interdisciplinary in nature, drawing from both Breast cancer, Transcription and Ovarian tumor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

7068 Citations

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

6803 Citations

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

4781 Citations

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Premal H Thaker;Liz Y Han;Aparna A Kamat;Jesusa M Arevalo.
Nature Medicine (2006)

1101 Citations

Advances and Challenges of Liposome Assisted Drug Delivery.

Lisa Sercombe;Tejaswi Veerati;Tejaswi Veerati;Fatemeh Moheimani;Sherry Y. Wu.
Frontiers in Pharmacology (2015)

1100 Citations

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

Michael H. Antoni;Susan K. Lutgendorf;Steven W. Cole;Firdaus S. Dhabhar.
Nature Reviews Cancer (2006)

1035 Citations

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

Charles N. Landen;Arturo Chavez-Reyes;Corazon Bucana;Rosemarie Schmandt.
Cancer Research (2005)

872 Citations

RNA interference in the clinic: challenges and future directions

Chad V. Pecot;George A. Calin;Robert L. Coleman;Gabriel Lopez-Berestein.
Nature Reviews Cancer (2011)

800 Citations

Dicer, Drosha, and outcomes in patients with ovarian cancer

William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat.
The New England Journal of Medicine (2008)

798 Citations

Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria.
Nature Reviews Cancer (2015)

685 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Anil K. Sood

Mauro Ferrari

Mauro Ferrari

Houston Methodist

Publications: 100

Michael J. Birrer

Michael J. Birrer

University of Arkansas for Medical Sciences

Publications: 83

George A. Calin

George A. Calin

The University of Texas MD Anderson Cancer Center

Publications: 77

David M. Gershenson

David M. Gershenson

The University of Texas MD Anderson Cancer Center

Publications: 67

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 65

Giovanni Scambia

Giovanni Scambia

Catholic University of the Sacred Heart

Publications: 55

Beth Y. Karlan

Beth Y. Karlan

University of California, Los Angeles

Publications: 49

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 49

Robert L. Coleman

Robert L. Coleman

The University of Texas MD Anderson Cancer Center

Publications: 48

Yuquan Wei

Yuquan Wei

Sichuan University

Publications: 48

Ignace Vergote

Ignace Vergote

KU Leuven

Publications: 47

Daniel J. Klionsky

Daniel J. Klionsky

University of Michigan–Ann Arbor

Publications: 47

Ben Davidson

Ben Davidson

Oslo University Hospital

Publications: 46

Jalid Sehouli

Jalid Sehouli

Charité - University Medicine Berlin

Publications: 43

David G. Huntsman

David G. Huntsman

University of British Columbia

Publications: 41

Douglas A. Levine

Douglas A. Levine

New York University

Publications: 40

Something went wrong. Please try again later.